Germany· DE-A57-ad1175a9f1dad7a4
Dopegyt
A medicinal product containing methyldopa sesquihydrate, registered in Germany by Cheplapharm Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Methyldopa Sesquihydrate
- Manufacturer
- Cheplapharm Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methyldopa sesquihydrate in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAldomet 250mg tabletsAspen Pharma Trading Ltd
- PolandDopegytInPharm Sp. z o.o.
- NetherlandsL-Methyldopa Teva 125 mg, omhulde tablettenTeva Nederland B.V.
- United StatesMethyldopaChartwell RX, LLC
- NorwayAldometAspen Global Health and Development
- CanadaMETHYLDOPAAA PHARMA INC
- FranceALDOMET 250 mg, comprimé enrobéHAC PHARMA
- FinlandMethyldopa MacureMacure Pharma ApS
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Aldometil
- Belgium · Aldomet
- Bulgaria · Допегит
- Cyprus · Dopamet, Methyldopa Remedica
- Czechia · Dopegyt
- Denmark · Methyldopa Macure
- Spain · Aldomet, Aldomet Forte
- Finland · Methyldopa Macure
- France · Aldomet
- United Kingdom (Northern Ireland) · Methyldopa, Methyldopa Accord-Uk
- Hungary · Dopegyt
- Italy · Aldomet
- Lithuania · Dopegyt
- Latvia · Dopegyt
- Malta · Methyldopa Remedica
- Netherlands · L-Methyldopa Teva, Methyldopa Cf
- Norway · Methyldopa Macure
- Poland · Dopegyt
- Portugal · Aldomet, Aldomet Forte
- Romania · Dopegyt
- Sweden · Methyldopa Macure
- Slovakia · Dopegyt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8d4f26b-b04a-4233-910e-821aaf0e71f8 GET /v1/drugs/b8d4f26b-b04a-4233-910e-821aaf0e71f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Methyldopa Sesquihydrate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about methyldopa sesquihydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.